SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 22, 2026

MDGL

MADRIGAL PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $456K total
Actionable Insight • Neutral

The dollar amounts are immaterial relative to MDGL's size, so no immediate bearish read-through. Monitor the next Form 4 filing for any escalation in insider selling volume or pattern, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$524.28
T+0 close · May 22, 2026 · via day close
Latest settled
+3.03%
T+60 · $540.16
Vs SPY
+0.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 26 $524.28entry
  2. T+1 · 6mo ago +0.65%α +0.63% · $527.67
  3. T+5 · 6mo ago −13.62%α −14.84% · $452.86
  4. T+20 · 5mo ago −0.82%α +1.13% · $520.00
  5. T+60 · 3mo ago +3.03%α +0.30% · $540.16

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Madrigal insiders (Director Levy and CMO Soergel) sold a combined $456K in open-market transactions, representing approximately 0.004% of MDGL's $11.8B market cap. The amount is trivial and does not convey material bearish signal, consistent with routine portfolio diversification or tax planning.

Key Financial Metrics

Direction
selling
Total Value
$456.0K
Insiders
2

Key Facts

  • Director Richard S. Levy sold 40 shares at $506.68 on 2026-05-22 for $20,267.
  • Chief Medical Officer David Soergel sold 844 shares at $515.90 on 2026-05-18 for $435,420.
  • Total cluster value of $456K is less than 0.1% of MDGL's $11.8B market cap.
  • Both sales were open-market transactions, not part of a pre-arranged 10b5-1 plan per available data.

Financial Impact

Two insiders sold shares totaling $456K, representing ~0.004% of market cap.

insider holdingsdilution

Risk Factors

  • No material risk identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MDGL-1779487347673

Track record

18 reports on MDGL

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  3. Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  4. Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  6. Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  7. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  8. Nov 3, 202613d ago 8-K Bullish 7/10 No price data
  9. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
  10. Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (11h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026